Pharma

Inferences:Government initiatives, particularly those supported by the NHS, are crucial in driving market growth. The aging population significantly contributes to the increasing demand...

Key TakeawaysIncreased accessibility to specialized treatment services in rural areas. Focused support for Aboriginal communities through culturally appropriate programs. Enhanced collaboration between health...

Key TakeawaysTafenoquine's approval accelerates malaria elimination efforts in multiple countries. The need for G6PD testing ensures safe administration, mitigating potential risks. Collaboration between...

Pacira BioSciences has bolstered its intellectual property portfolio by securing a new U.S. patent for its flagship pain therapy, EXPAREL. This latest achievement marks...

Key TakeawaysThe creation of a new functional category by MHLW underscores the ClotTriever's distinct clinical benefits. The partnership with Medikit is pivotal for...

Sobi is set to present a comprehensive range of data and analyses at the 66th Annual Meeting of the American Society of Hematology (ASH)...

H. Lundbeck A/S announced promising results from the RESOLUTION Phase IV trial, demonstrating that Vyepti (eptinezumab) significantly reduces the frequency of migraine days in...

Gilead Sciences, Inc. and Tubulis have forged a pivotal exclusive option and license agreement to spearhead the discovery and development of a cutting-edge antibody-drug...

Merck has secured the FDA’s Breakthrough Therapy designation for its investigational drug sacituzumab tirumotecan (sac-TMT). This approval targets patients battling advanced or metastatic nonsquamous...

Intra-Cellular Therapies, a biopharmaceutical leader in central nervous system disorders, has taken a significant step by submitting a supplemental New Drug Application (sNDA) to...

Key TakeawaysCefiderocol’s approval in Australia broadens treatment options for resistant infections. Shionogi’s strategic partnerships enhance global accessibility to critical antibiotics. Clinical trial success...

A significant advancement in cancer treatment was marked today as Immunocore secured reimbursement approval from England's National Health Service (NHS) for KIMMTRAK, offering a...

PharmaMar Group has successfully expanded its global footprint as Luye Pharma Group Ltd. secures conditional approval from China's NMPA for Zepzelca (lurbinectedin). This milestone...

Novo Nordisk is set to showcase 13 new abstracts, including three oral presentations, at the 66th Annual Meeting and Exposition of the American Society...

On December 16 at 11:00 AM, the ADD4KIDS project will host its third and final webinar, marking the culmination of efforts to accelerate pediatric...